Supreme Court to Hear Medtronic, Inc.'s Appeal of Boston Scientific Corporation's CRM Patent Win

Published: May 20, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court agrees to hear Medtronic's appeal of a patent infringement loss to rival Boston Scientific over cardiac rhythm management technology. The U.S. Supreme Court agreed to hear Medtronic's (NYSE:MDT) appeal of a lower court's decision that the medical device company infringes a cardiac rhythm therapy device patent owned by rival Boston Scientific (NYSE:BSX). Last September the U.S Court of Appeals for the Federal Circuit overturned a Delaware court's decision that Medtronic hadn't infringed on Boston Scientific's patents, finding that the lower court used "a legally incorrect allocation of the burden of proof" and remanding the case for reconsideration.

Help employers find you! Check out all the jobs and post your resume.

Back to news